Organon & Co. (NYSE:OGN) Hits New 52-Week High – Should You Buy?

Organon & Co. (NYSE:OGN) reached a new 52-week high during mid-day trading on Monday . The company traded as high as $13.77 and last traded at $13.7650, with a volume of 1003 shares traded. The stock had previously closed at $13.76.

Analyst Ratings Changes

Separately, Weiss Ratings downgraded Organon & Co. from a “hold (c)” rating to a “hold (c-)” rating in a research report on Monday, August 3rd. Five analysts have rated the stock with a Hold rating and two have given a Sell rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Reduce” and a consensus target price of $11.40.

Organon & Co. Trading Down 0.0%

The firm has a market capitalization of $3.61 billion, a PE ratio of 17.88, a P/E/G ratio of 1.27 and a beta of 1.55. The stock’s 50-day simple moving average is $13.58 and its 200-day simple moving average is $11.12. The company has a debt-to-equity ratio of 8.43, a quick ratio of 1.44 and a current ratio of 1.95.

Organon & Co. Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, September 10th. Investors of record on Friday, August 14th will be given a dividend of $0.02 per share. This represents a $0.08 dividend on an annualized basis and a yield of 0.6%. The ex-dividend date of this dividend is Friday, August 14th. Organon & Co.’s dividend payout ratio (DPR) is 10.39%.

Institutional Inflows and Outflows

Large investors have recently bought and sold shares of the company. Absolute Gestao de Investimentos Ltda. bought a new position in Organon & Co. in the 2nd quarter valued at approximately $9,007,000. Groupe la Francaise purchased a new stake in Organon & Co. in the second quarter worth approximately $10,499,000. VIRGINIA RETIREMENT SYSTEMS ET Al purchased a new stake in Organon & Co. in the second quarter worth approximately $770,000. California State Teachers Retirement System grew its holdings in shares of Organon & Co. by 1,142.8% in the second quarter. California State Teachers Retirement System now owns 4,064,911 shares of the company’s stock worth $55,039,000 after acquiring an additional 3,737,836 shares during the period. Finally, Readystate Asset Management LP bought a new stake in shares of Organon & Co. during the 2nd quarter valued at about $4,764,000. 77.43% of the stock is owned by hedge funds and other institutional investors.

About Organon & Co.

Organon & Co is a global healthcare company that was established as an independent, publicly traded entity following its spin-off from Merck & Co in June 2021. Headquartered in Jersey City, New Jersey, Organon focuses on delivering therapeutic solutions across women’s health, biosimilars, and established brands. The company’s creation reflected a strategic effort to concentrate on specialty pharmaceuticals and legacy products with proven patient impact.

In women’s health, Organon provides a broad portfolio of products addressing reproductive and gynecological conditions, including fertility treatments, contraception, and hormone replacement therapies.